4.4 Review

GSK3 signalling in neural development

Journal

NATURE REVIEWS NEUROSCIENCE
Volume 11, Issue 8, Pages 539-551

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nrn2870

Keywords

-

Categories

Funding

  1. Whitehall Foundation
  2. March of Dimes foundation
  3. US National Institutes of Health [1R01NS064288]

Ask authors/readers for more resources

Recent evidence suggests that glycogen synthase kinase 3 (GSK3) proteins and their upstream and downstream regulators have key roles in many fundamental processes during neurodevelopment. Disruption of GSK3 signalling adversely affects brain development and is associated with several neurodevelopmental disorders. Here, we discuss the mechanisms by which GSK3 activity is regulated in the nervous system and provide an overview of the recent advances in the understanding of how GSK3 signalling controls neurogenesis, neuronal polarization and axon growth during brain development. These recent advances suggest that GSK3 is a crucial node that mediates various cellular processes that are controlled by multiple signalling molecules - for example, disrupted in schizophrenia 1 (DISC1), partitioning defective homologue 3 (PAR3), PAR6 and Wnt proteins - that regulate neurodevelopment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available